Biographical Sketch
Omar A. Minai, MD, FCCP, DABSM, is a Staff Physician in the Department of Pulmonary, Allergy, and Critical Care Medicine and the Lung Transplant Center at Cleveland Clinic.
Dr. Minai’s main clinical and research interests include pulmonary hypertension, advanced COPD, sleep disorders and lung transplantation. He has authored or co-authored more than 30 publications primarily related to advanced lung diseases such as pulmonary arterial hypertension, emphysema, and lung transplantation.
He obtained his medical degree from the Aga Khan University in Karachi, Pakistan in 1990. He completed a residency in internal medicine at the University of Connecticut, and he was a Chief Resident. Dr. Minai completed his Pulmonary, Critical care, and Sleep Medicine training at the Cleveland Clinic in 1999, when he joined the faculty in the Department of Pulmonary, Allergy, and Critical Care Medicine.
Dr. Minai is board-certified in the fields of pulmonary medicine, critical care medicine and sleep medicine. He is a Fellow of the American College of Chest Physicians and a member of the American Thoracic Society and the American Academy of Sleep Medicine.
Specialty Interests
COPD, lung transplantation, lung volume reduction, pulmonary hypertension, Sleep Apnea
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate
with the pharmaceutical or medical device industries
to help develop medical breakthroughs or provide
medical education about recent trends. The
collaborations are reviewed as part of the Cleveland
Clinic’s procedures. The Cleveland Clinic publicly
discloses payments to its physicians and scientists
for speaking and consulting of
$5,000 or more per year, and any equity, royalties,
and fiduciary relationships in companies with which
they collaborate. In publicly disclosing this
information, the Cleveland Clinic tries to provide
information as accurately as possible about its
doctors’ connections with industry and those of their
immediate family members. As of 9/4/2008, Dr.
Minai has reported the financial relationships
with the companies listed below. Patients should feel
free to contact their doctor about any of the
relationships and how the relationships are overseen
by the Cleveland Clinic. To learn more about the
Cleveland Clinic’s policies on collaborations with
industry and innovation management, go to
our Integrity in Innovation page.
Consulting. Dr. Minai receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
Actelion
Gilead Sciences, Inc.
United Therapeutics
